A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending.

[1]  Nicole M. Acquisto,et al.  Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department. , 2023, Allergy and asthma proceedings.

[2]  Z. Liu,et al.  Total serum immunoglobulin E (IgE) as an effective predictor for identifying allergic asthma in childhood asthma. , 2023, Allergy and asthma proceedings.

[3]  Shou-gang Kuai,et al.  Association of EDN levels in patients with asthma and correlation with FEV1%: A meta-analysis. , 2023, Allergy and asthma proceedings.

[4]  M. Rank,et al.  Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: A scoping review. , 2023, Allergy and asthma proceedings.

[5]  A. Peters,et al.  Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis. , 2023, Allergy and asthma proceedings.

[6]  G. Karakaya,et al.  Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease. , 2023, Allergy and asthma proceedings.

[7]  Junbo Xia,et al.  Clinical value of serum soluble receptor for advanced glycation end products in evaluating the condition of patients with bronchial asthma. , 2023, Allergy and asthma proceedings.

[8]  T. Midoro-Horiuti,et al.  Peptide immunotherapy for aeroallergens. , 2023, Allergy and asthma proceedings.

[9]  T. Machnig,et al.  Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate. , 2023, Allergy and asthma proceedings.

[10]  J. Bellanti,et al.  The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist. , 2023, Allergy and asthma proceedings.

[11]  B. Graham.  The Journey to RSV Vaccines - Heralding an Era of Structure-Based Design. , 2023, The New England journal of medicine.

[12]  M. Ison,et al.  Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults. , 2023, The New England journal of medicine.

[13]  O. Ramilo,et al.  Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. , 2022, The Lancet. Infectious diseases.

[14]  R. Chanock,et al.  Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. , 1957, American journal of hygiene.

[15]  J. Morris,et al.  Recovery of Cytopathogenic Agent from Chimpanzees with Goryza , 1956 .